Effects of glycopyrronium bromide versus anisodamine hydrobromide in preventing nausea and vomiting and relieving spasm after ERCP: a randomized controlled trial
For patients undergoing ERCP under general anesthesia, a subcutaneous injection of 0.2 mg glycopyrronium bromide significantly reduces PONV and provides similar anti-spasmodic effects to 10 mg intramuscular anisodamine hydrobromide.
Authors
- Chunmu Miao
- Guangyou Duan (ORCID: https://orcid.org/0000-0002-6199-7882)
- Yi Yang (ORCID: https://orcid.org/0000-0002-9400-1850)
- Jie Liu (ORCID: https://orcid.org/0000-0003-0895-7598)
- Guizhen Chen
- Qingjing Ma
- Yan Rao
- Dina Sun
- Jie Chen (ORCID: https://orcid.org/0000-0001-7839-9806)
Institutions
- Chongqing University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PeerJ
- Published
- 2025-07-01
- DOI
- https://doi.org/10.7717/peerj.19582
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.00